Changing treatment strategy for gastrinoma in patients with Zollinger-Ellison syndrome.

Masayuki Imamura, Izumi Komoto, Shuichi Ota

Journal: World journal of surgery 2006;30(1):1-11

PMID: 16369713

Abstract

We overviewed the recent development of curative surgery for gastrinoma that has been rapidly improved since the development of new localization techniques, especially the selective arterial secretagogue injection test (SASI test) and somatostatin receptor scintigraphy (SRS). A number of new pathological findings of gastrinomas in patients with Zollinger-Ellison syndrome have been accumulated in accordance with the increase of curative resection of gastrinomas, and these new findings also have contributed to the progress of the treatment strategy for grastrinomas.

Address: Department of Surgery, Osaka Saiseikai Noe Hospital, Imafuku Higashi 2-2-33, Joto-ku, Osaka, 536-0002, Japan. [email protected]

DOI: 10.1007/s00268-005-0341-1

Link outs

Subscription / membership required

Full Text Sources:

MeSH Terms: Calcium, Duodenal Neoplasms, Duodenoscopy, Duodenum, Gastrinoma, Gastrointestinal Agents, Humans, Multiple Endocrine Neoplasia Type 1, Octreotide, Pancreatic Neoplasms, Secretin, Ultrasonography, Interventional, Zollinger-Ellison Syndrome